VS38 as a promising CD38 substitute antibody for flow cytometric detection of plasma cells in the daratumumab era

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

Jacques J. M. van Dongen, Ludovic Lhermitte, Sebastian Böttcher et al. · Leukemia · 2012 · 915 citations · Full text

Medicine, Cell Biology, Hematology +15

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

Juan Flores‐Montero, Luzalba Sanoja-Flores, Bruno Paiva et al. · Leukemia · 2017 · 657 citations · Full text

Medicine, Hematology, Oncology +15

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Bruno Paiva, María‐Belén Vídriales, Jorge Cerveró et al. · Blood · 2008 · 475 citations · Full text

Medicine, Hematology, Immunology +17

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Aurore Perrot, Valérie Lauwers‐Cancès, Jill Corre et al. · Blood · 2018 · 420 citations · Full text

Medicine, Hematology, Oncology +15

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

Andy C. Rawstron, J. A. Child, Ruth M. de Tute et al. · Journal of Clinical Oncology · 2013 · 419 citations

Medicine, Hematology, Oncology +17